0001752724-21-069494.txt : 20210401 0001752724-21-069494.hdr.sgml : 20210401 20210401091535 ACCESSION NUMBER: 0001752724-21-069494 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210131 FILED AS OF DATE: 20210401 PERIOD START: 20211031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OAK ASSOCIATES FUNDS CENTRAL INDEX KEY: 0001050918 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-08549 FILM NUMBER: 21796252 BUSINESS ADDRESS: STREET 1: C/O ULTIMUS FUND SOLUTIONS, LLC STREET 2: 225 PICTORIA DRIVE, SUITE 450 CITY: CINCINNATI STATE: OH ZIP: 45246 BUSINESS PHONE: 513-587-3405 MAIL ADDRESS: STREET 1: C/O ULTIMUS FUND SOLUTIONS, LLC STREET 2: 225 PICTORIA DRIVE, SUITE 450 CITY: CINCINNATI STATE: OH ZIP: 45246 0001050918 S000006543 ROCK OAK CORE GROWTH FUND C000017878 ROCK OAK CORE GROWTH FUND RCKSX NPORT-P 1 primary_doc.xml NPORT-P false 0001050918 XXXXXXXX S000006543 C000017878 Oak Associates Funds 811-08549 0001050918 54930064H3XUADDZTB14 3875 Embassy Parkway Suite 250 Akron 44333 888-462-5386 ROCK OAK CORE GROWTH FUND S000006543 549300NJK3HCQ5EYEH17 2021-10-31 2021-01-31 N 12121834.85 35108.38 12086726.47 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0 N Jazz Pharmaceuticals plc 635400GAUMJCLEZRRV50 Jazz Pharmaceuticals PLC G50871105 3655.00000000 NS USD 568352.50000000 4.702286441334 Long EC CORP IE N 1 N N N KLA Corporation 549300H0BF5JCG96TJ81 KLA-Tencor Corp. 482480100 2560.00000000 NS USD 716979.20000000 5.931955205403 Long EC CORP US N 1 N N N EXELIXIS, INC. N/A Exelixis, Inc. 30161Q104 14921.00000000 NS USD 331395.41000000 2.741812771411 Long EC CORP US N 1 N N N Assurant Inc. H3F39CAXWQRVWURFXL38 Assurant, Inc. 04621X108 1830.00000000 NS USD 247910.10000000 2.051093822759 Long EC CORP US N 1 N N N Pulte Group Inc N/A PulteGroup, Inc. 745867101 8820.00000000 NS USD 383670.00000000 3.174308618237 Long EC CORP US N 1 N N N NetApp Inc. QTX3D84DZDD5JYOCYH15 NetApp, Inc. 64110D104 5805.00000000 NS USD 385684.20000000 3.190973180019 Long EC CORP US N 1 N N N Colfax Corp 635400OP2DYYYMOIYL17 Colfax Corp. 194014106 10855.00000000 NS USD 402937.60000000 3.333719853759 Long EC CORP US N 1 N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina, Inc. 452327109 1060.00000000 NS USD 452026.40000000 3.739857943521 Long EC CORP US N 1 N N N The Hartford Financial Services Group, Inc. IU7C3FTM7Y3BQM112U94 Hartford Financial Services Group, Inc./The 416515104 9565.00000000 NS USD 459311.30000000 3.800129846075 Long EC CORP US N 1 N N N Amdocs Limited N/A Amdocs Ltd. G02602103 2475.00000000 NS USD 174784.50000000 1.446086336394 Long EC CORP GG N 1 N N N DraftKings Inc N/A DraftKings, Inc. 26142R104 9745.00000000 NS USD 527301.95000000 4.362653124556 Long EC CORP US N 1 N N N Cardinal Health, Inc. CCU46N3GJMF4OK4N7U60 Cardinal Health, Inc. 14149Y108 5770.00000000 NS USD 310022.10000000 2.564979862574 Long EC CORP US N 1 N N N Carlisle Companies Incorporated XR64VGX1ZPX6G7ZN7Z11 Carlisle Cos., Inc. 142339100 2485.00000000 NS USD 360151.05000000 2.979723673683 Long EC CORP US N 1 N N N Viatris Inc N/A Viatris, Inc. 92556V106 18120.00000000 NS USD 307858.80000000 2.547081716162 Long EC CORP US N 1 N N N TAL Ed Group 5493003PJZS0EC085V72 TAL Education Group 874080104 7315.00000000 NS USD 562377.20000000 4.652849565147 Long EC CORP KY N 1 N N Cyrusone Inc 5493006S177ZK2ZNBU43 CyrusOne, Inc. 23283R100 4465.00000000 NS USD 325721.75000000 2.694871525457 Long EC CORP US N 1 N N Quest Diagnostics Incorporated 8MCWUBXQ0WE04KMXBX50 Quest Diagnostics, Inc. 74834L100 2245.00000000 NS USD 289941.75000000 2.398844308420 Long EC CORP US N 1 N N N Cognizant Technolo 5493006IEVQEFQO40L83 Cognizant Technology Solutions Corp. 192446102 4500.00000000 NS USD 350775.00000000 2.902150560539 Long EC CORP US N 1 N N N Mount Vernon Liquid Assets Portfolio, LLC N/A Mount Vernon Liquid Assets Portfolio, LLC 000000000 2801386.5 PA USD 2801386.5 23.17737980546 Long STIV CORP US N N/A N N Citrix Systems Inc. HCTKJGUQOPZ5NBK7NP58 Citrix Systems, Inc. 177376100 2015.00000000 NS USD 268619.65000000 2.222435087504 Long EC CORP US N 1 N N N Republic Services, Inc. NKNQHM6BLECKVOQP7O46 Republic Services, Inc. 760759100 3130.00000000 NS USD 283327.60000000 2.344121881993 Long EC CORP US N 1 N N N Seagate Tech Plc 396PBGKP6TE3O062MS44 Seagate Technology PLC G7945M107 7998.00000000 NS USD 528827.76000000 4.375276972740 Long EC CORP IE N 1 N N N F5 Network Inc N/A F5 Networks, Inc. 315616102 2820.00000000 NS USD 552579.00000000 4.571783777613 Long EC CORP US N 1 N N N N/A N/A Prime Solutions 0.02% 2/1/21 N/A 406821.72000000 PA USD 406821.72000000 3.365855271150 Long RA CORP US N 2 Repurchase Y 0.02 2020-02-01 353173.11 USD 414958.77 USD UST N N N Solaredge Technologies Inc 5493000K6Y58XXPDF853 SolarEdge Technologies, Inc. 83417M104 1120.00000000 NS USD 322929.60000000 2.671770564193 Long EC CORP US N 1 N N N Ubiquiti Inc N/A Ubiquiti Networks, Inc. 90353W103 2565.00000000 NS USD 789994.35000000 6.536048879411 Long EC CORP US N 1 N N Transdigm Gp Inc 549300EQD0ZXRSMG3549 Transdigm Group 893641100 535.00000000 NS USD 296004.80000000 2.449007187634 Long EC CORP US N 1 N N N Iqiyi Inc 222100XL8T2Q5B8MS302 iQIYI, Inc. 46267X108 13155.00000000 NS USD 287436.75000000 2.378119093812 Long EC CORP KY N 1 N N Thor Industries 254900XZO1228PDSG060 Thor Industries, Inc. 885160101 3490.00000000 NS USD 422324.90000000 3.494121431871 Long EC CORP US N 1 N N Gentex Corp 549300S3UD8XV1MN0287 Gentex Corp. 371901109 12755.00000000 NS USD 421552.75000000 3.487733018913 Long EC CORP US N 1 N N N Pool Corporation 5493005VZK1KMN6CO617 Pool Corp. 73278L105 1030.00000000 NS USD 364805.40000000 3.018231618837 Long EC CORP US N 1 N N N 2020-03-31 Oak Associates Funds Gregory Knoth Gregory Knoth SVP XXXX NPORT-EX 2 oakassociatesnport.htm OAK N-PORT EX FILE

 

White Oak Select Growth Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 99.44% Shares Fair Value
COMMUNICATIONS - 16.64%
Internet Media & Services - 16.64%
Alphabet, Inc. - Class A(a) 11,750   $ 21,471,480  
Alphabet, Inc. - Class C(a) 14,695   26,976,199  
Facebook, Inc. - Class A(a) 63,650   16,442,705  
    64,890,384  
CONSUMER DISCRETIONARY - 18.03%
E-Commerce Discretionary - 12.92%
Amazon.com, Inc.(a) 15,705   50,353,371  
   
Retail - Discretionary - 5.11%
Lowe's Cos., Inc. 119,390   19,920,221  
   
CONSUMER STAPLES - 0.32%
Beverages - 0.32%
PepsiCo, Inc. 9,000   1,229,130  
   
FINANCIALS - 15.13%
Asset Management - 5.81%
Charles Schwab Corp. (The) 439,100   22,631,214  
   
Banking - 5.13%
JPMorgan Chase & Co. 155,565   20,016,549  
   
Institutional Financial Services - 0.76%
State Street Corp.(b) 42,200   2,954,000  
   
Insurance - 3.43%
Chubb Ltd. 91,890   13,385,616  
   
HEALTH CARE - 20.23%
Biotech & Pharma - 11.84%
Amgen, Inc. 82,460   19,908,318  
Novartis AG - ADR 160,990   14,564,765  
Pfizer, Inc. 305,700   10,974,630  
 
 

 

White Oak Select Growth Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 99.44%  (Continued) Shares Fair Value
HEALTH CARE - 20.23%  (Continued)
Biotech & Pharma - 11.84%  (Continued)
Viatris, Inc.(a) 41,653   $ 707,685  
    46,155,398  
Health Care Facilities & Services - 2.80%
Laboratory Corp. of America Holdings(a) 47,770   10,935,031  
   
Medical Equipment & Devices - 5.59%
Alcon, Inc.(a)(b) 138,000   9,895,980  
Zimmer Biomet Holdings, Inc. 77,390   11,892,521  
    21,788,501  
REAL ESTATE - 2.71%
REIT - 2.71%
Digital Realty Trust, Inc. 73,490   10,578,885  
   
TECHNOLOGY - 26.38%
Semiconductors - 16.21%
KLA Corp. 75,835   21,239,108  
Qualcomm, Inc. 122,300   19,113,044  
Xilinx, Inc. 174,905   22,837,346  
    63,189,498  
Software - 2.57%
Salesforce.com, Inc.(a) 44,375   10,009,225  
   
Technology Hardware - 5.60%
Cisco Systems, Inc. 490,000   21,844,200  
   
Technology Services - 2.00%
Cognizant Technology Solutions Corp. - Class A 100,000   7,795,000  
   
     
TOTAL COMMON STOCKS (Cost $195,031,789) 387,676,223  
     
     
 
 

 

White Oak Select Growth Fund
Schedule of Investments (Continued)
 
SHORT-TERM INVESTMENTS - 3.67% Shares Fair Value
REPURCHASE AGREEMENTS - 0.70%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $2,373,443 and a collateral value of $2,788,663 2,733,980   $   2,733,980  
   
COLLATERAL FOR SECURITIES LOANED - 2.97%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 11,581,345   11,581,345  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $14,315,325) 14,315,325  
     
     
TOTAL INVESTMENTS- 103.11% (Cost $209,347,114) 401,991,548  
   
Liabilities in Excess of Other Assets - (3.11)%     (12,110,710 )
   
NET ASSETS - 100.00% $ 389,880,838  
 

  

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $10,803,410.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

  

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 
 

  

Pin Oak Equity Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 97.80% Shares Fair Value
COMMUNICATIONS - 16.68%
Internet Media & Services - 16.68%
Alphabet, Inc. - Class A(a) 2,985   $ 5,454,670  
Alphabet, Inc. - Class C(a) 10,089   18,520,781  
Facebook, Inc. - Class A(a) 23,900   6,174,087  
    30,149,538  
CONSUMER DISCRETIONARY - 23.59%
Automotive - 5.35%
Gentex Corp. 292,500   9,667,125  
   
E-Commerce Discretionary - 14.10%
Amazon.com, Inc.(a) 5,120   16,415,744  
eBay, Inc. 160,500   9,069,855  
    25,485,599  
Leisure Facilities & Services - 4.14%
DraftKings, Inc. - Class A(a)(b) 138,555   7,497,211  
   
FINANCIALS - 10.99%
Asset Management - 5.85%
Charles Schwab Corp. (The) 205,351   10,583,791  
   
Institutional Financial Services - 2.22%
Bank of New York Mellon Corp. (The) 100,745   4,012,673  
   
Insurance - 2.92%
Assurant, Inc. 38,900   5,269,783  
   
HEALTH CARE - 23.80%
Biotech & Pharma - 7.23%
Amgen, Inc. 18,500   4,466,455  
Biogen, Inc.(a) 7,100   2,006,531  
Gilead Sciences, Inc. 37,085   2,432,776  
GlaxoSmithKline PLC - ADR(b) 111,760   4,163,060  
    13,068,822  
Health Care Facilities & Services - 4.59%
McKesson Corp. 36,500   6,368,155  
 
 

 

Pin Oak Equity Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 97.80%  (Continued) Shares Fair Value
HEALTH CARE - 23.80%  (Continued)
Health Care Facilities & Services - 4.59%  (Continued)
Quest Diagnostics, Inc. 15,000   $ 1,937,250  
    8,305,405  
Medical Equipment & Devices - 11.98%
Illumina, Inc.(a) 23,675   10,095,967  
Intuitive Surgical, Inc.(a) 8,040   6,011,025  
Medtronic PLC 49,845   5,549,244  
    21,656,236  
TECHNOLOGY - 22.74%
Semiconductors - 10.98%
KLA Corp. 35,275   9,879,469  
Xilinx, Inc. 76,300   9,962,491  
    19,841,960  
Technology Services - 11.76%
Amdocs Ltd. 81,587   5,761,674  
Paychex, Inc. 43,649   3,811,431  
PayPal Holdings, Inc.(a) 26,230   6,145,951  
Visa, Inc. - Class A(b) 28,720   5,550,140  
    21,269,196  
     
TOTAL COMMON STOCKS (Cost $99,080,843) 176,807,339  
     
     
SHORT-TERM INVESTMENTS - 8.95%    
REPURCHASE AGREEMENTS - 2.88%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $4,517,154 and a collateral value of $5,307,405 5,203,330   5,203,330  
   
 
 

 

Pin Oak Equity Fund
Schedule of Investments (Continued)
 
SHORT-TERM INVESTMENTS - 8.95%  (Continued) Shares Fair Value
COLLATERAL FOR SECURITIES LOANED - 6.07%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 10,967,477   $ 10,967,477  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $16,170,807) 16,170,807  
     
TOTAL INVESTMENTS- 106.75% (Cost $115,251,650) 192,978,146  
   
Liabilities in Excess of Other Assets - (6.75)%     (12,202,373 )
   
NET ASSETS - 100.00% $ 180,775,773  
 

 

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $10,446,706.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

 

The accompanying notes are an integral part of the quarterly schedule of investments.
 

  

 

 
 

 

Rock Oak Core Growth Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 96.76% Shares Fair Value
COMMUNICATIONS - 2.38%
Internet Media & Services - 2.38%
iQIYI, Inc. - ADR(a)(b) 13,155   $ 287,437  
   
CONSUMER DISCRETIONARY - 22.19%
Automotive - 3.49%
Gentex Corp. 12,755   421,553  
   
Consumer Services - 4.65%
TAL Education Group - ADR(a)(b) 7,315   562,377  
   
Home Construction - 3.18%
PulteGroup, Inc. 8,820   383,670  
   
Leisure Facilities & Services - 4.36%
DraftKings, Inc. - Class A(a) 9,745   527,302  
   
Leisure Products - 3.49%
Thor Industries, Inc.(b) 3,490   422,325  
   
Wholesale - Discretionary - 3.02%
Pool Corp. 1,030   364,805  
   
ENERGY - 2.67%
Renewable Energy - 2.67%
SolarEdge Technologies, Inc.(a) 1,120   322,929  
   
FINANCIALS - 5.85%
Insurance - 5.85%
Assurant, Inc. 1,830   247,910  
Hartford Financial Services Group, Inc. (The) 9,565   459,311  
    707,221  
HEALTH CARE - 18.69%
Biotech & Pharma - 9.99%
Exelixis, Inc.(a) 14,921   331,395  
Jazz Pharmaceuticals PLC(a) 3,655   568,353  
 
 

 

Rock Oak Core Growth Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 96.76%  (Continued) Shares Fair Value
HEALTH CARE - 18.69%  (Continued)
Biotech & Pharma - 9.99%  (Continued)
Viatris, Inc.(a) 18,120   $ 307,859  
    1,207,607  
Health Care Facilities & Services - 4.96%
Cardinal Health, Inc. 5,770   310,022  
Quest Diagnostics, Inc. 2,245   289,942  
    599,964  
Medical Equipment & Devices - 3.74%
Illumina, Inc.(a) 1,060   452,026  
   
INDUSTRIALS - 8.13%
Aerospace & Defense - 2.45%
TransDigm Group, Inc. 535   296,005  
   
Commercial Support Services - 2.35%
Republic Services, Inc. 3,130   283,327  
   
Machinery - 3.33%
Colfax Corp.(a)(b) 10,855   402,938  
   
MATERIALS - 2.98%
Construction Materials - 2.98%
Carlisle Cos., Inc. 2,485   360,151  
   
REAL ESTATE - 2.69%
REIT - 2.69%
CyrusOne, Inc.(b) 4,465   325,722  
   
TECHNOLOGY - 31.18%
Semiconductors - 5.93%
KLA Corp. 2,560   716,979  
   
Software - 2.22%
Citrix Systems, Inc. 2,015   268,620  
   
 
 

 

Rock Oak Core Growth Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 96.76%  (Continued) Shares Fair Value
TECHNOLOGY - 31.18%  (Continued)
Technology Hardware - 18.68%
F5 Networks, Inc.(a) 2,820   $ 552,579  
NetApp, Inc. 5,805   385,684  
Seagate Technology PLC 7,998   528,828  
Ubiquiti Networks, Inc.(b) 2,565   789,994  
    2,257,085  
Technology Services - 4.35%
Amdocs Ltd. 2,475   174,785  
Cognizant Technology Solutions Corp. - Class A 4,500   350,775  
    525,560  
     
TOTAL COMMON STOCKS (Cost $7,941,194) 11,695,603  
     
     
SHORT-TERM INVESTMENTS - 26.55%    
REPURCHASE AGREEMENTS - 3.37%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $353,173 and a collateral value of $414,959 406,822   406,822  
   
COLLATERAL FOR SECURITIES LOANED - 23.18%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 2,801,387   2,801,387  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $3,208,209) 3,208,209  
     
     
TOTAL INVESTMENTS- 123.31% (Cost $11,149,403) 14,903,812  
   
Liabilities in Excess of Other Assets - (23.31)%     (2,817,086 )
   
NET ASSETS - 100.00% $ 12,086,726  
 

  

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $2,762,647.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

 

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 
 

 

 

River Oak Discovery Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 98.93% Shares Fair Value
COMMUNICATIONS - 6.47%
Advertising & Marketing - 1.94%
QuinStreet, Inc.(a) 17,875   $ 378,414  
   
Internet Media & Services - 4.53%
Eventbrite, Inc. - Class A(a)(b) 49,500   883,575  
   
CONSUMER DISCRETIONARY - 12.33%
Consumer Services - 6.37%
Aaron's Co., Inc. (The)(a) 3,000   50,820  
Adtalem Global Education, Inc.(a) 19,770   762,924  
American Public Education, Inc.(a) 14,920   429,398  
    1,243,142  
Home Construction - 5.96%
M/I Homes, Inc.(a) 11,710   578,123  
Taylor Morrison Home Corp.(a) 22,580   586,628  
    1,164,751  
FINANCIALS - 16.13%
Asset Management - 8.34%
AllianceBernstein Holding LP 15,900   562,065  
Artisan Partners Asset Management, Inc. - Class A 12,620   610,808  
Hamilton Lane, Inc. - Class A 6,050   455,989  
    1,628,862  
Banking - 1.78%
Dime Community Bancshares, Inc. 21,870   347,733  
   
Insurance - 3.87%
CNO Financial Group, Inc. 17,345   367,887  
Selective Insurance Group, Inc. 5,960   387,281  
    755,168  
Specialty Finance - 2.14%
PROG Holdings, Inc. 8,850   417,543  
   
 
 

 

River Oak Discovery Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 98.93%  (Continued) Shares Fair Value
HEALTH CARE - 6.40%
Biotech & Pharma - 3.59%
United Therapeutics Corp.(a) 4,275   $ 700,330  
   
Health Care Facilities & Services - 2.81%
Magellan Health, Inc.(a) 5,850   549,783  
   
INDUSTRIALS - 12.14%
Commercial Support Services - 1.97%
Barrett Business Services, Inc. 6,101   384,668  
   
Electrical Equipment - 4.20%
Advanced Energy Industries, Inc.(a) 8,000   820,640  
   
Machinery - 5.97%
Hollysys Automation Technologies Ltd. 38,430   534,946  
Kadant, Inc.(b) 4,410   630,409  
    1,165,355  
MATERIALS - 2.04%
Forestry, Paper & Wood Products - 2.04%
Mercer International, Inc. 35,145   397,139  
   
TECHNOLOGY - 43.42%
Semiconductors - 24.26%
Ambarella, Inc.(a) 9,360   883,209  
Cirrus Logic, Inc.(a) 7,195   674,099  
Cohu, Inc. 27,400   1,114,632  
Diodes, Inc.(a) 6,870   486,259  
Kulicke & Soffa Industries, Inc. 25,285   901,916  
Silicon Motion Technology Corp. - ADR 13,665   675,188  
    4,735,303  
Software - 13.04%
FireEye, Inc.(a) 24,590   516,390  
NextGen Healthcare, Inc.(a) 33,665   665,894  
Verint Systems, Inc.(a) 7,760   572,921  
Workiva, Inc.(a)(b) 8,120   791,456  
    2,546,661  
 
 

 

River Oak Discovery Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 98.93%  (Continued) Shares Fair Value
TECHNOLOGY - 43.42%  (Continued)
Technology Services - 6.12%
LiveRamp Holdings, Inc.(a) 4,710   $ 356,594  
Perficient, Inc.(a) 8,630   471,284  
Perspecta, Inc. 12,690   367,376  
    1,195,254  
     
TOTAL COMMON STOCKS (Cost $12,722,489) 19,314,321  
     
     
SHORT-TERM INVESTMENTS - 12.22%    
REPURCHASE AGREEMENTS - 1.20%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $203,170 and a collateral value of $238,714 234,033   234,033  
   
COLLATERAL FOR SECURITIES LOANED - 11.02%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 2,150,601   2,150,601  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $2,384,634) 2,384,634  
     
     
TOTAL INVESTMENTS- 111.15% (Cost $15,107,123) 21,698,955  
   
Liabilities in Excess of Other Assets - (11.15)%     (2,176,302 )
   
NET ASSETS - 100.00% $ 19,522,653  
 

  

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $2,044,548.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

 

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 

 
 

 

Red Oak Technology Select Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 99.38% Shares Fair Value
COMMUNICATIONS - 13.70%
Internet Media & Services - 13.70%
Alphabet, Inc. - Class A(a) 9,250   $ 16,903,080  
Alphabet, Inc. - Class C(a) 17,636   32,375,111  
Facebook, Inc. - Class A(a) 143,225   36,999,314  
    86,277,505  
CONSUMER DISCRETIONARY - 10.75%
E-Commerce Discretionary - 10.75%
Amazon.com, Inc.(a) 15,400   49,375,480  
eBay, Inc. 324,030   18,310,935  
    67,686,415  
REAL ESTATE - 2.30%
REIT - 2.30%
Digital Realty Trust, Inc. 100,770   14,505,842  
   
TECHNOLOGY - 72.63%
Semiconductors - 25.85%
Intel Corp. 537,450   29,833,850  
KLA Corp. 143,000   40,050,010  
NXP Semiconductors NV 113,550   18,221,368  
Qualcomm, Inc. 153,200   23,942,096  
Skyworks Solutions, Inc. 145,135   24,564,099  
Xilinx, Inc. 200,585   26,190,383  
    162,801,806  
Software - 23.90%
Akamai Technologies, Inc.(a) 136,780   15,186,683  
Check Point Software Technologies Ltd.(a) 99,700   12,735,678  
Citrix Systems, Inc.(b) 129,280   17,234,317  
Microsoft Corp. 157,970   36,642,721  
Oracle Corp. 408,601   24,691,758  
Synopsys, Inc.(a) 99,295   25,364,908  
VMware, Inc. - Class A(a)(b) 135,470   18,674,540  
    150,530,605  
Technology Hardware - 15.98%
Apple, Inc. 487,000   64,264,520  
Cisco Systems, Inc. 576,180   25,686,104  
 
 

 

Red Oak Technology Select Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 99.38%  (Continued) Shares Fair Value
TECHNOLOGY - 72.63%  (Continued)
Technology Hardware - 15.98%  (Continued)
NetApp, Inc. 160,690   $ 10,676,244  
    100,626,868  
Technology Services - 6.90%
Accenture PLC - Class A 47,580   11,510,554  
Global Payments, Inc. 93,157   16,444,074  
Visa, Inc. - Class A 80,000   15,460,000  
    43,414,628  
     
TOTAL COMMON STOCKS (Cost $263,627,031) 625,843,669  
     
     
SHORT-TERM INVESTMENTS - 3.71%    
REPURCHASE AGREEMENTS - 0.61%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $3,311,691 and a collateral value of $3,891,053 3,814,752   3,814,752  
   
COLLATERAL FOR SECURITIES LOANED - 3.10%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 19,519,974   19,519,974  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $23,334,726) 23,334,726  
     
     
TOTAL INVESTMENTS- 103.09% (Cost $286,961,757) 649,178,395  
   
Liabilities in Excess of Other Assets - (3.09)%     (19,432,849 )
   
NET ASSETS - 100.00% $ 629,745,546  
 

 

(a) Non-income producing security.  

(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $18,781,035.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

 

  

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 

 
 

 

 

Black Oak Emerging Technology Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 96.94% Shares Fair Value
COMMUNICATIONS - 8.17%
Internet Media & Services - 8.17%
Facebook, Inc. - Class A(a) 5,525   $ 1,427,273  
iQIYI, Inc. - ADR(a)(b) 26,150   571,378  
Tencent Holdings Ltd. - ADR(b) 32,245   2,879,801  
    4,878,452  
CONSUMER DISCRETIONARY - 6.23%
Automotive - 3.22%
Tesla, Inc.(a) 2,425   1,924,310  
   
Leisure Facilities & Services - 3.01%
DraftKings, Inc. - Class A(a) 33,140   1,793,206  
   
ENERGY - 7.13%
Renewable Energy - 7.13%
SolarEdge Technologies, Inc.(a)(b) 14,765   4,257,192  
   
HEALTH CARE - 3.31%
Medical Equipment & Devices - 3.31%
Illumina, Inc.(a) 4,635   1,976,549  
   
INDUSTRIALS - 3.02%
Electrical Equipment - 3.02%
Advanced Energy Industries, Inc.(a)(b) 17,560   1,801,305  
   
TECHNOLOGY - 69.08%
Information Technology - 2.27%
Paylocity Holdings Corp.(a) 7,220   1,353,461  
   
Semiconductors - 28.40%
Ambarella, Inc.(a) 22,000   2,075,920  
Cirrus Logic, Inc.(a) 20,830   1,951,563  
Cohu, Inc.(b) 59,077   2,403,252  
Diodes, Inc.(a) 25,770   1,824,001  
KLA Corp. 7,590   2,125,731  
Kulicke & Soffa Industries, Inc. 49,645   1,770,837  
 
 

 

Black Oak Emerging Technology Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 96.94%  (Continued) Shares Fair Value
TECHNOLOGY - 69.08%  (Continued)
Semiconductors - 28.40%  (Continued)
Lam Research Corp. 4,285   $ 2,073,726  
Qualcomm, Inc. 10,844   1,694,700  
Silicon Motion Technology Corp. - ADR 20,940   1,034,646  
    16,954,376  
Software - 17.09%
Citrix Systems, Inc. 12,595   1,679,039  
Concentrix Corp.(a) 6,000   641,520  
Fortinet, Inc.(a) 11,090   1,605,277  
NextGen Healthcare, Inc.(a) 88,315   1,746,871  
Palo Alto Networks, Inc.(a) 5,100   1,788,825  
Salesforce.com, Inc.(a) 7,480   1,687,189  
Verint Systems, Inc.(a)(b) 14,335   1,058,353  
    10,207,074  
Technology Hardware - 10.68%
Apple, Inc. 20,120   2,655,035  
F5 Networks, Inc.(a) 7,705   1,509,795  
SYNNEX Corp. 4,000   326,480  
Ubiquiti Networks, Inc.(b) 6,120   1,884,899  
    6,376,209  
Technology Services - 10.64%
Cognizant Technology Solutions Corp. - Class A 9,600   748,320  
Jack Henry & Associates, Inc.(b) 8,120   1,175,695  
PayPal Holdings, Inc.(a) 7,250   1,698,747  
Perficient, Inc.(a) 31,260   1,707,109  
Science Applications International Corp.(b) 10,665   1,024,160  
    6,354,031  
     
TOTAL COMMON STOCKS (Cost $23,320,625) 57,876,165  
     
     
 
 

 

Black Oak Emerging Technology Fund    
Schedule of Investments (Continued)    
     
SHORT-TERM INVESTMENTS - 22.01% Shares Fair Value
REPURCHASE AGREEMENTS - 3.10%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $1,607,732 and a collateral value of $1,888,996 1,851,954   $ 1,851,954  
   
COLLATERAL FOR SECURITIES LOANED - 18.91%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 11,289,986   11,289,986  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $13,141,940) 13,141,940  
     
     
TOTAL INVESTMENTS- 118.95% (Cost $36,462,565) 71,018,105  
   
Liabilities in Excess of Other Assets - (18.95)%     (11,313,471 )
   
NET ASSETS - 100.00% $ 59,704,634  
 

  

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $10,853,707.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

  

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 

 
 

 

 

Live Oak Health Sciences Fund
Schedule of Investments
As of January 31, 2021 (Unaudited)
 
COMMON STOCKS - 98.91% Shares Fair Value
HEALTH CARE - 98.91%
Biotech - 26.49%
Alexion Pharmaceuticals, Inc.(a) 10,610   $ 1,626,831  
Amgen, Inc. 10,240   2,472,243  
Biogen, Inc.(a) 6,850   1,935,879  
Exelixis, Inc.(a) 66,265   1,471,746  
Gilead Sciences, Inc. 15,390   1,009,584  
Regeneron Pharmaceuticals, Inc.(a) 2,855   1,438,463  
United Therapeutics Corp.(a) 13,650   2,236,143  
Vertex Pharmaceuticals, Inc.(a) 4,315   988,480  
    13,179,369  
Health Care Services - 8.48%
Charles River Laboratories International, Inc.(a) 11,015   2,853,436  
Quest Diagnostics, Inc. 10,545   1,361,887  
    4,215,323  
Health Care Supply Chain - 16.49%
AmerisourceBergen Corp. 14,440   1,504,648  
Cardinal Health, Inc. 17,409   935,385  
Cigna Corp. 15,148   3,287,873  
McKesson Corp. 14,206   2,478,521  
    8,206,427  
Large Pharma - 11.93%
GlaxoSmithKline PLC - ADR(b) 51,490   1,918,002  
Johnson & Johnson 7,688   1,254,143  
Merck & Co., Inc. 18,800   1,448,916  
Novartis AG - ADR 14,600   1,320,862  
    5,941,923  
Life Science & Diagnostics - 4.32%
Illumina, Inc.(a) 5,035   2,147,125  
   
Managed Care - 10.38%
Anthem, Inc. 5,415   1,608,147  
Humana, Inc. 2,500   957,775  
UnitedHealth Group, Inc. 7,800   2,601,924  
    5,167,846  
 
 

 

Live Oak Health Sciences Fund
Schedule of Investments (Continued)
 
COMMON STOCKS - 98.91%  (Continued) Shares Fair Value
HEALTH CARE - 98.91%  (Continued)
Medical Devices - 10.56%
Medtronic PLC 18,746   $ 2,086,992  
Stryker Corp. 7,060   1,560,331  
Zimmer Biomet Holdings, Inc. 10,460   1,607,388  
    5,254,711  
Medical Equipment - 7.19%
Alcon, Inc.(a)(b) 28,995   2,079,232  
Intuitive Surgical, Inc.(a) 2,005   1,499,018  
    3,578,250  
Specialty & Generic Pharma - 3.07%
Jazz Pharmaceuticals PLC(a) 9,295   1,445,373  
Viatris, Inc.(a) 4,636   78,766  
    1,524,139  
     
TOTAL COMMON STOCKS (Cost $33,111,436) 49,215,113  
     
     
SHORT-TERM INVESTMENTS - 9.63%    
REPURCHASE AGREEMENTS - 1.15%
Tri-Party Repurchase Agreement with South Street Securities LLC and Bank of New York Mellon, 0.02%, dated 1/29/2021 and maturing 2/1/2021, collateralized by U.S. Treasury Securities with rates ranging from 0.13% to 0.38% and maturity dates ranging from 1/15/2024 to 1/15/2027 with a par value of $495,637 and a collateral value of $582,346 570,926   570,926  
   
COLLATERAL FOR SECURITIES LOANED - 8.48%
Mount Vernon Liquid Assets Portfolio, LLC, 0.15%(c) 4,219,839   4,219,839  
     
TOTAL SHORT-TERM INVESTMENTS (Cost $4,790,765) 4,790,765  
     
 
 

 

Live Oak Health Sciences Fund    
Schedule of Investments (Continued)    
     
    Fair Value
TOTAL INVESTMENTS- 108.54% (Cost $37,902,201) $ 54,005,878  
   
Liabilities in Excess of Other Assets - (8.54)%     (4,251,380 )
   
NET ASSETS - 100.00% $ 49,754,498  
 

 

(a) Non-income producing security.  
(b) Security, or a portion of the security position, is currently on loan. The total market value of securities on loan is $3,957,254.
(c) Rate disclosed is the seven day effective yield as of January 31, 2021.

 

ADR - American Depositary Receipt.
 

 

The accompanying notes are an integral part of the quarterly schedule of investments.
 

 

 

Notes to Quarterly Schedule of Investments

As of January 31, 2021 (Unaudited)

1. ORGANIZATION:

The Oak Associates Funds (the “Trust”), a Massachusetts business trust, is registered under the Investment Company Act of 1940, as amended, as an open-end management investment company with seven diversified funds: White Oak Select Growth Fund, Pin Oak Equity Fund, Rock Oak Core Growth Fund, River Oak Discovery Fund, Red Oak Technology Select Fund, Black Oak Emerging Technology Fund and Live Oak Health Sciences Fund (collectively referred to as “Funds” and individually referred to as a “Fund”). The investment objective of each Fund is to seek long-term capital growth. The assets of each Fund are segregated, and a shareholder’s interest is limited to the Fund in which shares are held. The Funds’ prospectus provides a description of each Fund’s investment objective, policies and strategies.

2. SIGNIFICANT ACCOUNTING POLICIES:

The following is a summary of significant accounting policies followed by the Funds.

Use of Estimates – These policies are in conformity with generally accepted accounting principles in the United States of America (“GAAP”). Each Fund is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standard Codification Topic 946 “Financial Services - Investment Companies.” The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures of contingent assets and liabilities in the financial statements and the reported amounts of income and expenses during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the financial statements may differ from the value the Funds ultimately realize upon the sale of the securities.

Security Valuation – Investments in equity securities, which are traded on a national exchange, are stated at the last quoted sales price if readily available for such equity securities on each business day. Investments in equity securities, which are reported on the NASDAQ national market system are valued at the official closing price; other equity securities traded in the over-the-counter market and listed equity securities for which no sale was reported on that date are stated at the last quoted bid price. Debt obligations exceeding sixty days to maturity for which market quotations are readily available are valued at the most recently quoted bid price. Debt obligations with sixty days or less remaining until maturity may be valued at their amortized cost, which approximates market value, in the absence of a current quoted bid price. Investments in repurchase agreements are generally valued at par each business day.

Redeemable securities issued by open-end registered investment companies are valued at the investment company’s applicable net asset value (“NAV”) as determined by those funds each business day.

Securities for which market prices are not “readily available” are valued in accordance with Fair Value Procedures established by the Funds’ Board of Trustees (the “Board”). The Board of Trustees has determined to delegate responsibility for pricing and fair valuation determinations for portfolio securities to Funds’ adviser, Oak Associates, Ltd. (“Oak” or the “Adviser”), subject to oversight of the Board of Trustees. Oak may, in turn and subject to its oversight, delegate pricing of securities for which market prices are readily available to the Funds’ administrator. All fair valuation determinations shall be made by Oak’s Fair Value Committee (the “Committee”), in accordance with policies and procedures established by the Board of Trustees and subject to oversight of the Board. Oak and the administrator have established and maintain policies and procedures reasonably designed to ensure that their pricing and valuation policies and procedures conform to the requirements of the Funds’ Fair Value Procedures. Some of the more common reasons that may necessitate that a security be valued using Fair Value Procedures include: the security’s trading has been halted or suspended; the security has been de–listed from a national exchange; the security’s primary trading market is temporarily closed at a time when under normal conditions it would be open; the security has not been traded for an extended period of time; the security’s primary pricing source is not able or willing to provide a price; a significant event with respect to a security or securities has occurred after the close of the market or exchange on which the security or securities principally trades and before the time the Fund calculates net asset value; or trading of the security is subject to local government–imposed restrictions. When a security is valued in accordance with the Fair Value Procedures, the Committee will determine the value after taking into consideration relevant information reasonably available to the Committee.

Security Transactions and Investment Income – Security transactions are accounted for on the date the security is purchased or sold (trade date) for financial reporting purposes. Dividend income is recognized on the ex-dividend date. Interest income is recognized on the accrual basis. Withholding taxes on foreign dividends have been provided for in accordance with the Funds’ understanding of the applicable country’s tax rules and rates. Costs used in determining realized gains and losses on the sales of investment securities are those of the specific securities sold. If applicable, any foreign capital gains taxes are accrued, net of unrealized gains, and are payable upon the sale of such investments.

Expenses – Expenses that are directly related to one of the Funds are charged to that Fund. Expenses not directly billed to a particular Fund are allocated proportionally among all Funds daily in relation to net assets of each Fund or another reasonable allocation method.

Repurchase Agreements – The Funds may invest in tri-party repurchase agreements. Securities held as collateral for tri-party repurchase agreements are maintained by the broker’s custodian bank in a segregated account until maturity of the repurchase agreement. Provisions of the repurchase agreements and procedures adopted by the Board of Trustees require that the market value of the collateral, including accrued interest thereon, is sufficient in the event of default by the counterparty. A custody agreement in connection with the Master Repurchase Agreement

 
 

defines eligible securities for collateral in relation to each repurchase agreement. Under the Master Repurchase Agreement, if the counterparty defaults and the value of the collateral declines or if the counter-party enters an insolvency proceeding, realization of the collateral by the Funds may be delayed or limited.

Master Agreements and Netting Arrangements – Certain Funds may participate in various repurchase agreements, such as, but not limited to Master Repurchase Agreements, which govern the terms of certain transactions with select counterparties (collectively “Master Agreements”). These Master Agreements generally include provisions for general obligations, agreements, representations, collateral and provisions for events of default or termination. These Master Agreements also include provisions for netting arrangements that help reduce credit and counterparty risk associated with relevant transactions. The netting arrangements are generally tied to credit related events that if triggered, would cause an event of default or termination giving a Fund or counterparty the right to terminate early and cause settlement, on a net basis, of all transactions under the applicable Master Agreement. In the event of an early termination or default event, the total market value exposure would be offset against collateral exchanged to date, which would result in a net receivable or payable that would be due from or to the counterparty. Credit related events include, but are not limited to, bankruptcy, failure to make timely payments, restructuring, obligation acceleration, obligation default, a material decline in net assets, decline in credit rating or repudiation/moratorium. An election made by a counterparty to terminate a transaction early under a Master Agreement could have an adverse impact on a Fund’s financial statements. Master Agreements can also help limit counterparty risk by requiring collateral posting arrangements at pre-arranged exposure levels. Collateral under the Master Agreements is usually in the form of cash, U.S. Treasury or U.S. Government agency securities, but may include other types of securities. There can be no assurance that the Master Agreements will be successful in limiting credit or counterparty risk.

Securities Lending – The Trust has entered into a Securities Lending Agreement (“SLA”) with U.S. Bank National Association (the “Agent”). Under the terms of the SLA, the Funds may lend securities to certain broker-dealers and banks in exchange for collateral in the amount of at least 102% of the value of U.S. securities loaned or at least 105% of the value of non-U.S. securities loaned, marked to market daily. The collateral can be received in the form of cash collateral and/or non-cash collateral. Non-cash collateral can include U.S. Government Securities and letters of credit. The cash collateral is invested in the Mount Vernon Liquid Assets Portfolio, LLC (“Mount Vernon”), as noted in each lending Fund’s respective Schedule of Investments. Mount Vernon seeks to maximize current income to the extent consistent with the preservation of capital and liquidity; and to maintain a stable NAV of $1.00. The market value of the loaned securities is determined daily at the close of business of the Funds and any additional required collateral is delivered to each Fund on the next business day. The Funds continue to benefit from interest or dividends on the securities loaned and may also earn a return from the collateral. The Funds pay various fees in connection with the investment of cash collateral. The Funds pay the Agent fees based on the investment income received from securities lending activities. Although risk is mitigated by the collateral, the Funds could experience a delay in recovering its securities and possible loss of income or value if the borrower fails to return them. The contractual maturity of repurchase agreements are on an overnight and continuous basis. Cash and cash equivalent collateral on securities lending transactions are on an overnight and continuous basis.

 

The following is a summary of each Funds’ securities lending agreements and related cash and non-cash collateral received as of January 31, 2021:

  Market Value of Cash Collateral
  Securities on Loan Received
White Oak Select Growth Fund  $10,803,410   $11,581,345 
Pin Oak Equity Fund  10,446,706   10,967,477 
Rock Oak Core Growth Fund  2,762,647   2,801,387 
River Oak Discovery Fund  2,044,548   2,150,601 
Red Oak Technology Select Fund  18,781,035   19,519,974 
Black Oak Emerging Technology Fund  10,853,707   11,289,986 
Live Oak Health Sciences Fund  3,957,254   4,219,839 

 

Dividends and Distributions to Shareholders – Dividends from net investment income are declared and paid to shareholders on an annual basis, as applicable. Net realized capital gains on sales of securities, if any, are distributed to shareholders at least annually. Distributions to shareholders are determined in accordance with income tax regulations and are recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with federal income tax regulations, which may differ from GAAP. Therefore, the source of the Funds’ distributions may be shown in the accompanying financial statements as either accumulated earnings, or from paid-in capital, depending upon the type of book/tax differences that may exist.

 
 

3. Unrealized Appreciation and Depreciation on Investments (Tax Basis):

 

At January 31, 2021, the total cost of securities for Federal income tax purposes and the aggregate gross unrealized appreciation and depreciation for securities held by the Funds is as follows:

Fund Federal Tax Cost Gross Appreciation Gross Depreciation Net Appreciation
White Oak Select Growth Fund  $208,558,597   $194,129,289   $(696,338)  $193,432,951 
Pin Oak Equity Fund  115,043,688   78,291,655   (357,197)  77,934,458 
Rock Oak Core Growth Fund  11,134,620   3,776,658   (7,466)  3,769,192 
River Oak Discovery Fund  15,034,062   6,798,456   (133,563)  6,664,893 
Red Oak Technology Select Fund  286,065,767   363,535,684   (423,056)  363,112,628 
Black Oak Emerging Technology Fund  36,426,704   34,666,972   (75,571)  34,591,401 
Live Oak Health Sciences Fund  38,361,803   16,332,749   (688,674)  15,644,075 

As of January 31, 2021, the difference between book basis and tax basis unrealized appreciation (depreciation) is primarily attributable to wash sales, return of capital adjustments and partnership basis adjustments.

4. FAIR VALUE MEASUREMENTS:

A three-tier hierarchy has been established to classify fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability including assumptions about risk. Inputs may be observable and unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability that are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability that are developed based on the best information available.

Various inputs are used in determining the value of each Fund’s investments as of the reporting period end. The designated input levels are not necessarily an indication of the risk or liquidity associated with these investments. These inputs are categorized in the following hierarchy under applicable financial accounting standards:

The three-tier hierarchy is summarized as follows:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that a Fund has the ability to access at the measurement date, including but not limited to:

Equity Securities – investments for which market quotations are readily available that are valued at the last reported sale price or official closing price as reported by an independent pricing service on the primary market or exchange on which they are traded.

Investment Companies – investments in open-end registered investment companies which are valued at their closing NAV.

Level 2 – Quoted prices which are not active, quoted prices for similar assets or liabilities inactive markets or inputs other than quoted prices that are observable (either directly or indirectly) for substantially the full term of the asset or liability, including but not limited to:

Repurchase Agreements – investments in overnight tri-party repurchase agreements which are valued at par.

All Securities – quoted prices for similar securities, including matrix pricing; quoted prices based on recently executed transactions; adjusted quoted prices based on observable and formulaic inputs; or, prices using other observable correlated market inputs.

Level 3 – Significant unobservable prices or inputs (including the Fund’s own assumptions in determining the fair value of investments) where there is little or no market activity for the asset and liability at the measurement date, including but not limited to:

All Securities – modeling or manual pricing based on the Adviser’s own assumptions in determining fair value of investments; or, the significant use of other unobservable or very stale inputs within fair valuation.

 
 

The following is a summary of the inputs used to value each Fund’s investments as of January 31, 2021:

  Level 1 Level 2 Level 3 Total
WHITE OAK SELECT GROWTH FUND        
Common Stocks  $387,676,223   $-     $-     $387,676,223 
Short Term Investments        
   Repurchase Agreements  -     2,733,980   -     2,733,980 
   Collateral for Securities Loaned*  -     -     -     11,581,345 
Total  $387,676,223   $2,733,980   $-     $401,991,548 
         
PIN OAK EQUITY FUND        
Common Stocks  $176,807,339   $-     $-     $176,807,339 
Short Term Investments        
   Repurchase Agreements  -     5,203,330   -     5,203,330 
   Collateral for Securities Loaned*  -     -     -     10,967,477 
Total  $176,807,339   $5,203,330   $-     $192,978,146 
         
ROCK OAK CORE GROWTH FUND        
Common Stocks  $11,695,603   $-     $-     $11,695,603 
Short Term Investments        
   Repurchase Agreements  -     406,822   -     406,822 
   Collateral for Securities Loaned*  -     -     -     2,801,387 
Total  $11,695,603   $406,822   $-     $14,903,812 
         
RIVER OAK DISCOVERY FUND        
Common Stocks  $19,314,321   $-     $-     $19,314,321 
Short Term Investments        
Repurchase Agreements  -     234,033   -     234,033 
   Collateral for Securities Loaned*  -     -     -     2,150,601 
Total  $19,314,321   $234,033   $-     $21,698,955 
         
RED OAK TECHNOLOGY SELECT FUND        
Common Stocks  $625,843,669   $-     $-     $625,843,669 
Short Term Investments  -         
   Repurchase Agreements  -     3,814,752   -     3,814,752 
   Collateral for Securities Loaned*  -     -     -     19,519,974 
Total  $625,843,669   $3,814,752   $-     $649,178,395 
         
BLACK OAK EMERGING TECHNOLOGY FUND        
Common Stocks  $57,876,165   $-     $-     $57,876,165 
Short Term Investments        
   Repurchase Agreements    1,851,954   -     1,851,954 
   Collateral for Securities Loaned*  -     -     -     11,289,986 
Total  $57,876,165   $1,851,954   $-     $71,018,105 
         
LIVE OAK HEALTH SCIENCES FUND        
Common Stocks  $49,215,113   $-     $-     $49,215,113 
Short Term Investments        
   Repurchase Agreements  -     570,926   -     570,926 
   Collateral for Securities Loaned*  -     -     -     4,219,839 
Total  $49,215,113   $570,926   $-     $54,005,878 

 
 

 

* Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Schedules of Investments.

The above tables are presented by levels of disaggregation for each asset class. For detailed descriptions of the underlying industries, see the accompanying Schedules of Investments. There were no Level 3 securities held during the period.